Eligibility, Compliance and Persistence of Sequential Therapy with Aromatase Inhibitors following 2–3 Years of Tamoxifen in Endocrine Adjuvant Breast Cancer Therapy

Oncology ◽  
2011 ◽  
Vol 81 (3-4) ◽  
pp. 151-157 ◽  
Author(s):  
Nerbil Kilic ◽  
Mary Elizabeth Myrick ◽  
Seraina Margaretha Schmid ◽  
Uwe Gueth
Keyword(s):  
Breast Cancer ◽  
Cancer Therapy ◽  
Aromatase Inhibitors ◽  
Sequential Therapy ◽  
Breast Cancer Therapy ◽  
Adjuvant Breast Cancer

scholarly journals Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: how often and how often does it work?

2011 ◽  
Vol 129 (3) ◽  
pp. 799-807 ◽  
Author(s):  
Uwe Güth ◽  
Mary Elizabeth Myrick ◽  
Andreas Schötzau ◽  
Nerbil Kilic ◽  
Seraina Margaretha Schmid
Keyword(s):  
Breast Cancer ◽  
Side Effects ◽  
Cancer Therapy ◽  
Breast Cancer Therapy ◽  
Adverse Side Effects ◽  
Adjuvant Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document